SCHEMBL950885

SCHEMBL950885

OCC(O)c1ccc(O)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.62
HIF1A Q16665 3/20 0.62
TSHR P16473 2/20 0.62
NFKB1 P19838 2/20 0.62
HTR3A P46098 1/20 0.62
TDP1 Q9NUW8 3/20 0.60
KDM4E B2RXH2 3/20 0.60
ALOX15 P16050 3/20 0.60
APEX1 P27695 1/20 0.60
CYP2C9 P11712 2/20 0.56
ALDH1A1 P00352 2/20 0.56
THPO P40225 2/20 0.56
BLM P54132 2/20 0.56
HTR1A P08908 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NMUR2 Q9GZQ4 1/20 0.56
CYP3A4 P08684 3/20 0.47
ESR1 P03372 8/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7895108 1.00 TAAR1 (0.62) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL17438169 0.89 TSHR (0.48) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL1338106 0.81 TSHR (0.44) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL15240750 0.80 TAAR1 (0.58) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL7220167 0.79 TSHR (0.42) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL7066863 0.79 TAAR1 (0.62) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL27673834 0.78 TAAR1 (0.56) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL17669227 0.78 TAAR1 (0.50) TAAR1HIF1ATSHRNFKB1HTR3A
Hydroquinone SCHEMBL28129289 0.77 ALOX15 (0.53) TAAR1HIF1ATSHRNFKB1HTR3A
SCHEMBL24015469 0.77 TSHR (0.46) TAAR1HIF1ATSHRNFKB1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130232852-A1 METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN THESIS CHEMISTRY, LLC (US) 2013-09-12 US claimed
WO-2013134756-A1 A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN Vertichem Corporation (CA) 2013-09-12 WO claimed
US-4157286-A Production of 1,2-bis(hydroxyphenyl)ethane-1,2-diols by electrolytic reduction MONSANTO COMPANY (US) 1979-06-05 US claimed
CN-118340754-B Compound for treating heart failure and related diseases and application thereof 源道医药(苏州)有限公司 2025-03-11 CN disclosed
CN-119490387-A Compounds for the treatment of pain-related diseases 源道医药(苏州)有限公司 2025-02-21 CN disclosed
CN-119301201-A Cured product, photosensitive resin composition, dry film, and printed wiring board 太阳控股株式会社 2025-01-10 CN disclosed
CN-118340754-A Compound for treating heart failure and related diseases and application thereof 源道医药(苏州)有限公司 2024-07-16 CN disclosed
CN-117737020-A Method for producing p-hydroxyphenylethanol 杭州唯铂莱生物科技有限公司 2024-03-22 CN disclosed
US-20240066075-A1 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING EYE DISORDERS MarvelBiome, Inc. 2024-02-29 US disclosed
CN-108795044-B C-grade VPI impregnating resin for electric locomotive and preparation method thereof 丹阳市沃德立电工材料有限公司 2021-07-20 CN disclosed
WO-2020249117-A1 ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF 华东理工大学 2020-12-17 WO disclosed
US-20080003308-A1 Composition Based on Vegetal Extracts of Ajuga Reptans for Preventing Hair Loss, Stimulating the Growth of Hair, Regulating the Production of Sebum GIULIANI S.P.A. (IT) 2008-01-03 US disclosed
EP-1863430-A1 COMPOSITION BASED ON VEGETAL EXTRACTS OF AJUGA REPTANS FOR PREVENTING HAIR LOSS, STIMULATING THE GROWTH OF HAIR, REGULATING THE PRODUCTION OF SEBUM. GIULIANI S.p.A. (IT) 2007-12-12 EP disclosed
WO-2006100101-A1 COMPOSITION BASED ON VEGETAL EXTRACTS OF AJUGA REPTANS FOR PREVENTING HAIR LOSS, STIMULATING THE GROWTH OF HAIR, REGULATING THE PRODUCTION OF SEBUM. GIULIANI S.P.A. (IT) 2006-09-28 WO disclosed
EP-0375368-B1 Alcohol and ether derivatives ZENECA LTD (GB) 1995-08-16 EP disclosed
US-5232916-A Inhibitors of leukotriene synthesis MERCK FROSST CANADA, INC. (CA) 1993-08-03 US disclosed
US-5102881-A Leukotriene biosynthesis inhibitor MERCK FROSST CANADA, INC. (CA) 1992-04-07 US disclosed
WO-1991014377-A1 PROCESSING OF MIXTURES CONTAINING LIPIDS AND PROTEINS AND PRODUCTS SO PRODUCED PORTWALL PTY LIMITED (AU) 1991-10-03 WO disclosed
CN-1052680-A ANIONIC POLYMERIZATION CATALYST COMPOSITIONS SHELL INT RESEARCH (NL) 1991-07-03 CN disclosed
US-4157286-A Production of 1,2-bis(hydroxyphenyl)ethane-1,2-diols by electrolytic reduction MONSANTO COMPANY (US) 1979-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130232852-A1 METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN DCXR, AGL, GLO1 TAAR1 3865/4885HIF1A 2627/4885TSHR 4782/4885
US-20080003308-A1 Composition Based on Vegetal Extracts of Ajuga Reptans for Preventing Hair Loss, Stimulating the Growth of Hair, Regulating the Production of Sebum SHBG, AR, NR5A1 TAAR1 4310/4885HIF1A 290/4885TSHR 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.